Back
Foghorn Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
FHTX
Foghorn Therapeutics, Inc.
Last Price:
$5.56
Seasonality Move:
-12.48%
7 Day Trial
ALL ACCESS PASS
$
7
Foghorn Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 17.5% based on the past 5 years of stock performance.
-
Foghorn Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Foghorn Therapeutics, Inc. Stock Undervalued?The current Foghorn Therapeutics, Inc. [FHTX] share price is $5.55. The Score for FHTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
FHTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Foghorn Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Foghorn Therapeutics, Inc. has on average historically fallen by 17.5% based on the past 5 years of stock performance.
Foghorn Therapeutics, Inc. Stock Rating
Sell
40
Foghorn Therapeutics, Inc. (FHTX)
is a Sell
Is Foghorn Therapeutics, Inc. overpriced?
-
Foghorn Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Foghorn Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
foghorntx.com
52-Week Data
52-Week High:
6.95
52-Week Low:
2.94
Prediction Charts
Market Cap:
325.1M
Price in USD:
5.55
Volume:
121K
Beta:
3.00
Technical Analysis
SMA50:
5.31
SMA100:
4.89
SMA200:
4.91
52-Wk Change:
-9.9%
Stock Predictions
-
Is Foghorn Therapeutics, Inc. stock public?Yes, Foghorn Therapeutics, Inc. is a publicly traded company.
-
What is the Foghorn Therapeutics, Inc. stock quote today?The Foghorn Therapeutics, Inc. stock price is 5.55 USD today.
-
How to buy Foghorn Therapeutics, Inc. stock online?You can buy Foghorn Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 5.78 | 5.90 | 5.95 | 5.73 |
| Jan-28 | 5.92 | 5.87 | 5.94 | 5.69 |
| Jan-29 | 5.83 | 5.77 | 5.93 | 5.68 |
| Jan-30 | 5.63 | 5.71 | 5.80 | 5.46 |
| Feb-2 | 5.71 | 5.85 | 5.98 | 5.71 |
| Feb-3 | 5.86 | 5.69 | 6.00 | 5.51 |
| Feb-4 | 5.72 | 5.63 | 5.77 | 5.39 |
| Feb-5 | 5.58 | 5.23 | 5.79 | 5.18 |
| Feb-6 | 5.38 | 5.68 | 5.74 | 5.25 |
| Feb-9 | 5.64 | 5.45 | 5.66 | 5.40 |
| Feb-10 | 5.44 | 5.45 | 5.64 | 5.37 |
| Feb-11 | 5.53 | 5.42 | 5.59 | 5.11 |
| Feb-12 | 5.49 | 5.26 | 5.49 | 5.13 |
| Feb-13 | 5.29 | 5.55 | 5.74 | 5.29 |
Foghorn Therapeutics, Inc. Earnings
Foghorn Therapeutics, Inc. Earnings Report: Per Share Foghorn Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Foghorn Therapeutics, Inc. Forecast Revenue Growth
Foghorn Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Foghorn Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.10 per share.
* Foghorn Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.